E. Kubota

发表

Efficient isolation of mutant antigen presenting cell lines by functional selection using T cell clones.

M. Tokushima, K. Miyake, M. Kimoto, 1995, Journal of immunological methods.

Immunohistochemical demonstration of bcl-2 protein in ameloblastoma.

K. Kimura, N. Nakamura, M. Ohishi, 1997, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

Generation of intestinal T cells from progenitors residing in gut cryptopatches.

T. Iwanaga, H. Takahashi-Iwanaga, H. Nariuchi, 1998, Science.

The possible use of spleen cells for the adoptive immunotherapy of cancer patients

Hiroshi Yamamoto, T. Katsuki, M. Katano, 2004, Surgery Today.

Autologous tumour-specific cytotoxic T-cell clone established from tumour-infiltrating lymphocytes (TIL) of malignant ascites in the absence of recombinant interleukin 2(rIL2): Activation by autologous tumour cell alone

T. Hisatsugu, M. Katano, J. Tadano, 1993, Biotherapy.

Intraepithelial T Cells Extrathymic Maturation of Intestinal Role of Gut Cryptopatches in Early

S. Kaminogawa, Kenji Suzuki, E. Kubota, 2013 .

Role of Gut Cryptopatches in Early Extrathymic Maturation of Intestinal Intraepithelial T Cells1

S. Kaminogawa, H. Ishikawa, Y. Kanamori, 2000, The Journal of Immunology.

Modulation of F1 cytotoxic potentials by GvHR: suppression of cytotoxic T cell responses of F1 mice correlates with F1 inability to resist the proliferation of GvHR-inducing parental T lymphocytes.

K. Saito, E. Kubota, H. Ishikawa, 1982, Journal of immunology.

Role of T cells in the B-cell response: glutaraldehyde-fixed T-helper hybridoma cells synergize with the lymphokine IL-4 to induce B-cell activation and proliferation.

S. Swain, R. Dutton, E. Kubota, 1991, Immunology.

Effective Induction of Human NK Cells with OK‐432 and Further Augmentation of Their Cytolytic Function by rIL‐2

H. Imamura, M. Katano, E. Kubota, 1994, Microbiology and immunology.

Signal transmission through the B cell-specific MB-1 molecule at the pre-B cell stage.

M. Kimoto, N. Sakaguchi, J. Nomura, 1991, International immunology.

Gut cryptopatches: direct evidence of extrathymic anatomical sites for intestinal T lymphopoiesis.

T. Hibi, K. Suzuki, H. Yamamoto, 2000, Immunity.

Tumoricidal effect of human PBMC following stimulation with OK-432 and its application for locoregional immunotherapy in head and neck cancer patients.

T. Hisatsugu, H. Imamura, M. Katano, 1993, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

Clear cell odontogenic carcinoma. A case report with massive invasion of neighboring organs and lymph node metastasis.

T. Shimokama, O. Tokunaga, H. Imamura, 1992, Oral surgery, oral medicine, and oral pathology.

Fetal calf serum-injected F1 mice spontaneously generate specific anti-parental cytotoxic T lymphocytes in in vitro culture.

R. Dutton, K. Saito, E. Kubota, 1983, Cellular immunology.

Evaluation of the serum level of immunosuppressive substance in oral cancer patients.

E. Kubota, T. Katsuki, H. Kurokawa, 1991, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

Inhibition of tumor cell growth by a human B-cell line

M Katano, E Kubota, F Nagumo, 1994, Biotherapy.

Increased proliferation of a human breast carcinoma cell line by recombinant interleukin-2

Fumio Nagumo, Tatsuya Matsuo, T. Morisaki, 1994, Cancer Immunology, Immunotherapy.

Modulation of F1 cytotoxic potentials by GvHR: role and mode of action of non-MHC genes that determine the hybrid resistance to GvHR-associated suppression of F1 cytotoxic potential.

K. Saito, E. Kubota, H. Ishikawa, 1984, Journal of immunology.

Modulation of F1 cytotoxic potentials by GvHR. Host- and donor-derived cytotoxic lymphocytes arise in the unirradiated F1 host spleens under the condition of GvHR-associated immunosuppression.

K. Saito, E. Kubota, H. Ishikawa, 1983, Journal of immunology.

A possible clinical application of multicytokine-producing cytotoxic mononuclear cell (MCCM) therapy

K. Tabuchi, T. Hisatsugu, Hiroshi Yamamoto, 1991, Biotherapy.

Locoregional immunotherapy of head and neck cancers utilizing allogeneic spleen cells — a report of 2 cases

H. Imamura, T. Katsuki, M. Katano, 1993, Biotherapy.